INNO-GENE SA ZY -10 (WQ3) — Capital Reinvestment Ratio
INNO-GENE SA ZY -10 (WQ3) has a Capital Reinvestment Ratio of 12.04x as of June 2025, meaning it reinvests 12% of its operating cash flow (€54.00K) in capital expenditures (€650.00K). Check how tangible is INNO-GENE SA ZY -10's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
INNO-GENE SA ZY -10 Capital Reinvestment Ratio (2021–2021)
This chart tracks INNO-GENE SA ZY -10's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see INNO-GENE SA ZY -10 cash flow conversion.
Annual Capital Reinvestment Ratio for INNO-GENE SA ZY -10 (2021–2021)
Year-by-year Capital Reinvestment Ratio for INNO-GENE SA ZY -10 from 2021 to 2021. See INNO-GENE SA ZY -10 free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.01x | €6.75 Million | €82.00K | — |